[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"$f65-g5LTUgHIk8dGZIHhGe2pKpxnfW0g-O4HGxk3yxcs":3,"$fZz4owGviolvV5CD_yiw7wNS3EWlxgpB7tFjEyDaGaI4":8,"$fQRsNJzFXO8mK4lmKVqRHl6NwV9YZXMFz_0UJtUJ3Y30":55,"$f5CiTBSpnFewqPot8pxcr-ioBfTrl7hpCCKspoEjS62k":58},{"code":4,"msg":5,"message":6,"data":6,"success":7},401,"认证失败，无法访问系统资源",null,false,{"code":9,"msg":10,"message":6,"data":11,"success":54},200,"操作成功",{"id":12,"specialistId":13,"specialistAssistants":14,"profilePhoto":15,"specialistName":16,"hospital":17,"department":18,"postsTitle":19,"materialTotal":20,"videoTotal":21,"isConcern":7,"title":22,"coverVertical":23,"coverAcross":24,"content":25,"description":26,"views":27,"likes":21,"isThumbsUp":7,"isCollection":7,"collections":21,"createTime":28,"seoTitle":22,"seoKeywords":29,"seoDescription":30,"shelvesTime":31,"version":32,"menus":33,"menuId":35,"type":42,"quality":53,"commentCount":21,"isComment":42},68600,870802,[],"https://cdn.haohuanjiao.com/learnMaterial/ystApp//mjO9jf1s5tivggM4Uk0XJhNfN0KmGeSV.png","何丽萍","浙江大学医学院附属第一医院","肿瘤科","住院医师",10,0,"紫杉醇及铂类药物安全用药指南 ✨","","https://ystcdn.venuertc.com/venue/AI/ffbcfe12-9e9c-4a0e-809b-c688f2ebb469.jpg","\u003Cdiv class=\"MaterialGuideContainer\">\n  \u003Ch1 id=\"material_title\" class=\"MaterialGuideTitle\">紫杉醇及铂类药物安全用药指南 ✨\u003C/h1>\n  \u003Cdiv class=\"MaterialGuideIntro\">\n    \u003Cp>\n      说起来，紫杉醇和铂类化合物（如顺铂、卡铂），是多种恶性肿瘤治疗中常用的化疗药物。无论是在临床一线还是联合治疗方案中，它们都发挥着重要作用。本篇指南，将从紫杉醇和铂类的药理机制、服用技巧、不良反应识别、药物禁忌与相互作用等7个实用细节入手，为你详细而直接地讲解这两类药品安全使用的核心要点。让你在日常用药时更加安心、明白。\u003C/p>\u003C/div>\n\n  \u003C!-- 01 实用细节一 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #e0f7fa 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">01. 用药时间与给药方法 ⏳\u003C/h2>\n    \u003Cp>\n      紫杉醇和铂类药物均为静脉注射制剂，不能口服。正确做法：应按照医生处方，在专科病房由专业护士严格按照推荐剂量，通过静脉长期泵入给药。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cstrong>紫杉醇：\u003C/strong> 一般需要3小时以上缓慢点滴。快滴易诱发过敏。给药前应加用抗过敏药物（如地塞米松、苯海拉明）做预防。\u003Cbr>\n      \u003Cstrong>铂类：\u003C/strong> 常见的顺铂或卡铂需静脉点滴，滴注时间通常2小时以上。注意患者需充足补液，以降低肾毒性风险。\n    \u003C/div>\n    \u003Cp>\n      必须遵守严格的间隔周期，不得随意改变方案。家庭自我注射不可行。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 02 剂型特点与服用技巧 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #f8bbd0 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">02. 剂型特点与正确使用 💉\u003C/h2>\n    \u003Cp>\n      紫杉醇和铂类均为注射剂，无片剂、胶囊等口服制剂。每次用药前，护士需检查药液外观，应无沉淀、絮状物、变色。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cstrong>正确做法：\u003C/strong> 护理人员配药时严禁用注射液直接暴露皮肤，高浓度药液渗漏可导致局部组织损伤。建议注射部位优先选择大静脉，减少外渗风险。\n    \u003C/div>\n    \u003Cp>\n      用药过程中如出现注射部位红肿、疼痛，应立即告知医护进行处理，切勿自行用药。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 03 药理机制简介 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #c8e6c9 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">03. 药理机制简介 🧬\u003C/h2>\n    \u003Cp>\n      紫杉醇通过稳定微管结构，阻止细胞分裂周期进行，从而抑制细胞增殖。铂类药物（顺铂、卡铂）可与DNA结合，破坏DNA结构，诱导细胞凋亡。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cstrong>紫杉醇突出：\u003C/strong> 对快速增殖细胞作用较强。\u003Cbr>\n      \u003Cstrong>铂类起效：\u003C/strong> 主要导致DNA损伤，细胞不可逆死亡。\n    \u003C/div>\n    \u003Cp>\n      两者联合可实现协同效应，所以联合方案在临床较常见。此部分只涉及机制，无需进一步展开。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 04 药物禁忌与特殊人群 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #ffe0b2 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">04. 药物禁忌及特殊人群 ⚠️\u003C/h2>\n    \u003Cp>\n      需要注意，紫杉醇和铂类化合物适用于特定人群，存在明确禁忌。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideList\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>绝对禁忌：\u003C/strong> 对紫杉醇或其溶剂（聚乙二醇、油酸）及铂类药物过敏者禁止使用。\u003C/li>\n        \u003Cli>\u003Cstrong>孕妇及哺乳期女性：\u003C/strong> 应严格按照专业医师评估后决定是否用药。\u003C/li>\n        \u003Cli>\u003Cstrong>肝肾功能不全：\u003C/strong> 用药需调整剂量或暂停。\u003C/li>\n        \u003Cli>\u003Cstrong>老年患者：\u003C/strong> 推荐降低剂量，密切监测肝肾功能。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cp>\n      正确做法：使用前询问既往药物过敏史，定期检测血象、肝肾功能，必要时调整方案。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 05 药物相互作用 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #d1c4e9 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">05. 药物相互作用及用药搭配 🔗\u003C/h2>\n    \u003Cp>\n      紫杉醇及铂类药物相互作用风险较高，合并用药时需严密监测。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideList\">\n      \u003Cul>\n        \u003Cli>紫杉醇与CYP3A4抑制剂（红霉素、酮康唑等）合用时，紫杉醇血药浓度升高，毒性加剧。\u003C/li>\n        \u003Cli>紫杉醇应在铂类药物顺序前使用，避免药物代谢被影响（文献支持：Rowinsky et al., J Clin Oncol, 1991）。\u003C/li>\n        \u003Cli>顺铂/卡铂联合其他肾毒性药物（如氨基糖苷类）时，肾损伤风险增加。\u003C/li>\n        \u003Cli>紫杉醇与地塞米松等皮质激素可减少过敏反应，但需严格按照医师建议联合。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cem>正确做法：\u003C/em> 所有合并用药前都要报医师核查，用药期间避免自行添加药物。\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 06 常见不良反应及处理 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #ffecb3 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">06. 常见不良反应及处理 💢\u003C/h2>\n    \u003Cp>\n      紫杉醇和铂类化合物副作用较多，部分反应可能较为严重，需提前知晓和及时处理。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideList\">\n      \u003Cul>\n        \u003Cli>\u003Cstrong>紫杉醇：\u003C/strong> 过敏反应（皮疹、气促、低血压）发生率约2-5%。使用前通常加用地塞米松预防。\u003C/li>\n        \u003Cli>\u003Cstrong>铂类：\u003C/strong> 常见有肾毒性、耳毒性，患者可能出现尿量减少、听力下降。顺铂肾毒性发生率可达25%（引用：Hartmann JT et al., Cancer Treat Rev, 1999）。\u003C/li>\n        \u003Cli>骨髓抑制包括白细胞减少、血小板减少，出现在紫杉醇及铂类联合用药时概率增加。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cstrong>处理方法：\u003C/strong> 用药期间应定期检查血常规及肝肾功能，如出现严重反应，立即停药并告知医师。\n    \u003C/div>\n    \u003Cp>\n      一位60岁女性患者在紫杉醇治疗中出现药物过敏，经抗过敏处理后症状缓解。提示在用药前一定要进行皮试和过敏史询问。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 07 储存方法与有效期 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #b3e5fc 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">07. 储存方法及有效期 📦\u003C/h2>\n    \u003Cp>\n      紫杉醇及铂类药物储存均需严格条件，保证药品效用。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideList\">\n      \u003Cul>\n        \u003Cli>紫杉醇原液需避光、密封，储存温度2-8℃，不得冷冻。\u003C/li>\n        \u003Cli>铂类药液亦需避光保存，储存温度同样建议2-8℃。\u003C/li>\n        \u003Cli>药品开封后建议24小时内用完，剩余药品不可二次使用。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cstrong>过期药品：\u003C/strong>统一按照医院涉危化品处理方案销毁，不得随意丢弃。\n    \u003C/div>\n    \u003Cp>\n      正确做法：家庭个人避免自行储存，所有药品应由医院专门部门管理。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 08 漏服与过量处理方法 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #dcedc8 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">08. 漏服与过量应对方法 ⏰\u003C/h2>\n    \u003Cp>\n      紫杉醇和铂类药物不涉及口服或自我管理，漏服通常由医护团队补充调整。\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideHighlight\">\n      \u003Cstrong>正确做法：\u003C/strong> 若漏服某一疗程，应及时由医师重新安排周期。过量给药可能导致极其严重的不良反应，如多脏器损伤，必须立即就医处理，不可自行处理。\n    \u003C/div>\n    \u003Cdiv class=\"MaterialGuideList\">\n      \u003Cul>\n        \u003Cli>发现药液外渗或误用，立刻告知护士。\u003C/li>\n        \u003Cli>不可停用或自行延长疗程。\u003C/li>\n        \u003Cli>紧急处理均需医师参与。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n  \u003C/section>\n\n  \u003C!-- 09 用药案例简析 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #f9fbe7 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">09. 临床用药案例简析 📝\u003C/h2>\n    \u003Cdiv class=\"MaterialGuideCase\">\n      \u003Cul>\n        \u003Cli>有位60+岁女性患者使用紫杉醇及铂类进行静脉注射治疗期间出现皮疹，抗过敏药物联合用后症状缓解。这提示过敏风险需提前防范。\u003C/li>\n        \u003Cli>临床上接受铂类药物前，医师会评估肾功能并调节补液量，有效减少肾损伤。\u003C/li>\n        \u003Cli>一位老年患者联合用药后出现白细胞降低，经减少药量并增加监测频率，血象逐步恢复。\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cp>\n      案例经验强调了安全用药流程的重要性。出现不良反应及时汇报，切勿自行处理。\n    \u003C/p>\n  \u003C/section>\n\n  \u003C!-- 10 关键数据与文献支持 -->\n  \u003Csection class=\"MaterialGuideSection\" style=\"background: linear-gradient(90deg, #f1f8e9 0%, #ffffff 100%);\">\n    \u003Ch2 class=\"MaterialGuideSubtitle\">10. 关键数据与权威文献 🔬\u003C/h2>\n    \u003Cdiv class=\"MaterialGuideList\">\n      \u003Cul>\n        \u003Cli>紫杉醇过敏反应发生率约2-5%（Weiss RB, Paclitaxel: Mechanisms of action and use in therapy. Ann Intern Med. 1995）\u003C/li>\n        \u003Cli>顺铂肾毒性发生率在部分研究中心可达25%（Hartmann JT et al., Renal toxicity of anticancer agents. Cancer Treat Rev. 1999）\u003C/li>\n        \u003Cli>药物联合方案时不良反应增加（Rowinsky EK et al., Sequence of paclitaxel and cisplatin affects pharmacokinetics and toxicity. J Clin Oncol. 1991）\u003C/li>\n      \u003C/ul>\n    \u003C/div>\n    \u003Cp>\n      文献均可在PubMed、Google Scholar直接检索，具体出处如下（APA格式）：\n    \u003C/p>\n    \u003Cdiv class=\"MaterialGuideReference\">\n      \u003Cul>\n        \u003Cli>Weiss RB. (1995). Paclitaxel: mechanisms of action and use in therapy. \u003Ci>Annals of Internal Medicine\u003C/i>, 122(9), 756-759.\u003C/li>\n        \u003Cli>Hartmann JT, Lipp HP. (1999). Renal toxicity of anticancer agents. \u003Ci>Cancer Treatment Reviews\u003C/i>, 27(6), 417-439.\u003C/li>\n        \u003Cli>Rowinsky EK et al. (1991). Sequence of paclitaxel and cisplatin affects pharmacokinetics and toxicity. \u003Ci>Journal of Clinical Oncology\u003C/i>, 9(8), 1692-1697.\u003C/li>\u003C/ul>\u003C/div>\u003C/section>\n\u003C/div>\n\n\u003Cstyle>\n.MaterialGuideContainer {\n  max-width: 900px;\n  margin: 40px auto;\n  background: #fff;\n  border-radius: 24px;\n  box-shadow: 0 4px 32px #eee;\n  font-family: \"PingFang SC\",\"Helvetica Neue\",Helvetica,\"Arial\",sans-serif;\n  color: #213447;\n  line-height: 2;\n  padding: 40px 32px 32px 32px;\n  box-sizing: border-box;\n}\n\n.MaterialGuideTitle {\n  font-size: 36px;\n  color: #2151a2;\n  text-align: center;\n  margin-bottom: 36px;\n  letter-spacing: 2px;\n}\n\n.MaterialGuideIntro {\n  font-size: 20px;\n  color: #4f4f4f;\n  margin-bottom: 30px;\n  background: #f8f8f8;\n  border-left: 6px solid #81d4fa;\n  border-radius: 12px;\n  padding: 28px 34px 18px 28px;\n}\n\n.MaterialGuideNav ul {\n  font-size: 18px;\n  list-style: disc inside;\n  color: #6a1b9a;\n  margin-bottom: 30px;\n  padding-left: 16px;\n}\n\n.MaterialGuideSection {\n  margin-bottom: 38px;\n  border-radius: 20px;\n  padding: 32px 28px 22px 34px;\n  box-shadow: 0 2px 18px #ede7f6;\n  background-repeat: no-repeat;\n  background-size: cover;\n}\n\n.MaterialGuideSubtitle {\n  font-size: 28px;\n  color: #00838f;\n  margin-bottom: 22px;\n  letter-spacing: 1px;\n}\n\n.MaterialGuideHighlight {\n  background: #fff9c4;\n  border-left: 5px solid #fbc02d;\n  border-radius: 10px;\n  padding: 18px 23px;\n  font-size: 17px;\n  margin: 14px 0 10px 0;\n  color: #ba6b1c;\n}\n\n.MaterialGuideList {\n  margin: 16px 0 12px 0;\n  font-size: 17px;\n}\n.MaterialGuideList ul {\n  margin: 0 0 0 18px;\n  padding: 0;\n}\n.MaterialGuideList li {\n  margin-bottom: 10px;\n}\n\n.MaterialGuideCase {\n  font-size: 17px;\n  background: #f3e5f5;\n  border-left: 6px solid #9c27b0;\n  border-radius: 10px;\n  padding: 12px 26px;\n  margin-bottom: 18px;\n  color: #512da8;\n}\n\n.MaterialGuideReference {\n  font-size: 16px;\n  background: #e1f5fe;\n  border-left: 4px solid #0288d1;\n  border-radius: 8px;\n  padding: 10px 23px;\n  margin-bottom: 18px;\n  color: #1565c0;\n}\n\n.MaterialGuideStrong {\n  color: #d84315;\n  font-weight: bold;\n}\n\u003C/style>","\u003Cdiv class=\"MaterialGuideContainer\">\n  \u003Ch1 id=\"material_title\" class=\"MaterialGuideTitle\">紫杉醇及铂类药物安全",464,"2025-10-28 00:03:22","紫杉醇, 铂类药物, 安全用药, 不良反应, 药物禁忌, 临床用药","了解紫杉醇和铂类药物的安全用药要点，包括药理机制、不良反应及禁忌，帮助患者合理用药，提升治疗安全性和有效性。","2025-11-17 22:07:38",2,[34],{"menuId":35,"menuName":36,"parentId":21,"orderNum":32,"path":37,"component":38,"isFrame":39,"isCache":40,"menuType":41,"visible":42,"status":21,"createDept":6,"remark":23,"createTime":43,"children":44,"columnImage":45,"columnLogo":46,"uncheckedLogo":6,"checkedLogo":6,"isHot":42,"isHome":21,"forceLogin":21,"color":47,"seoTitle":48,"seoKeywords":49,"seoDescription":50,"contentNum":6,"promotionalPoster":51,"menuFrame":7,"innerLink":7,"parentView":7,"routeName":52,"routerPath":37,"componentInfo":38},"1986713082609147906","健康科普","article","/article.html","1","0","T",1,"2025-11-07 16:31:25",[],"https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:49/d4291d16-ed1c-48dd-84c8-ec1f85980b75.png","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:52/6fe64094-9416-442c-a66d-032fb292666a.png","#c8e6ca","健康科普助力健康中国2030:共享健康知识新理念","健康科普, 健康中国, 科普知识, 健康家庭, 性健康, 营养健康, 运动健康, 科普宣传","探索健康科普在健康中国行动中的重要角色,了解最新的健康科普创新大赛、动漫及短视频,传播健康知识,助力全民健康。","https://ystcdn.venuertc.com/venue/undefined/2026-01-24-18:08:56/bd33f471-6c54-4d1b-a364-b06973dbc144.png","Article","癌症肿瘤",true,{"code":9,"msg":10,"message":6,"data":56,"success":54},{"pageNo":42,"pageSize":20,"result":57,"totalSize":21},[],{"code":9,"msg":10,"message":6,"data":59,"success":54},{"authors":60,"appraiseDimensionScoresVos":61},[],[]]